Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® Compared to SYMBICORT® TURBOHALER®
- Study Title
- Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAXֲ® as Compared to SYMBICORTֲ® TURBOHALERֲ® as Treatment for Adult Patients With Asthma
- Teva Identifier
- BFS-AS-40035 | 2013-004630-14
- ClinicalTrials.gov Identifier
- NCT02062463
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX | Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 75 Years
- Trial Duration
- 06/01/2014 - 04/01/2015
- Phase
- Phase 4
